Nycomed and Ayanda AS signs exclusive distribution agreement
Nycomed will distribute the exciting new patent-pending CONCORDIX™ delivery system manufactured by Ayanda, in the Norwegian pharmacy sector starting in the first quarter of 2010. The CONCORDIX™ technology will be marketed under Nycomed’s brand name Nycoplus SmartKidz.
About Nycomed:
Nycomed is a privately owned global pharmaceutical company with a differentiated portfolio focused
on branded medicines in
gastroenterology, respiratory and inflammatory diseases, pain, osteoporosis and tissue management. An extensive range of OTC
products completes the portfolio.
Its R&D is structured around partnerships, and in-licensing is a cornerstone of the company's growth strategy.
The company employs 12,000 associates worldwide, and its products are available in more than 100 countries. It has strong
platforms in Europe and in fast-growing markets such as Russia/CIS, and Latin America. While the US and Japan are commercialised
through best-in-class partners, Nycomed plans to further strengthen its own position in key Asian markets.
Headquartered
in Zurich, Switzerland, the company generated total sales of
€ 3,2 billion in 2009 and an adjusted EBITDA of € 1,1 billion.
Nycomed's commercial ad can been seen here: http://www.youtube.com/watch?v=6rJo6WwQLV0
Download full press release to the right (in Norwegian).